Shire

Servier expands global footprint post Shire deal

https://pharmaphorum.com/news/servier-expands-footprint-shire/

Roche haemophilia data piles pressure on Shire

https://pharmaphorum.com/news/roche-haemophilia-data-piles-pressure-on-shire/

Takeda to cut IT, marketing and sales jobs after Shire merger

https://pharmaphorum.com/news/takeda-to-cut-it-marketing-and-sales-jobs-after-shire-merger/

Takeda takes biggest gamble of 2018 with Shire merger

https://pharmaphorum.com/news/takeda-biggest-gamble-of-2018-with-shire-merger/

BMS’ Opdivo shines as infectious disease franchise fades

https://pharmaphorum.com/news/bms-opdivo-shines-as-infectious-disease-franchise-fades/

Shire recommends Takeda’s £46bn bid

https://pharmaphorum.com/news/shire-recommends-takedas-46bn-bid/

Takeda woos Shire shareholders with increased bid

https://pharmaphorum.com/news/takeda-woos-shire-shareholders-with-increased-bid/

Allergan says not interested in buying Shire

https://pharmaphorum.com/news/allergan-says-not-interested-in-buying-shire/

Roche haemophilia drug gets fast FDA review in expanded use

https://pharmaphorum.com/news/roches-haemophilia-drug-breakthrough-expanded-use-fda/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search